Megan Boston - 09 Dec 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Executive Director, Director
Signature
/s/ Megan Boston
Issuer symbol
BNTC
Transactions as of
09 Dec 2024
Net transactions value
$0
Form type
4
Filing time
11 Dec 2024, 17:17:43 UTC
Previous filing
08 Mar 2024
Next filing
20 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +720,000 $0.000000 720,000 09 Dec 2024 Common Stock 720,000 $12.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.